Clinical Trials Logo

Neoplasms, Basal Cell clinical trials

View clinical trials related to Neoplasms, Basal Cell.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03509467 Completed - Melanoma (Skin) Clinical Trials

Using MC1R Genotype to Impact Melanoma Risk Behavior

Start date: August 3, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.

NCT ID: NCT00847912 Completed - Carcinoma Clinical Trials

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

VAKCCT
Start date: June 26, 2009
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to see if 5-fluorouracil (5-FU) skin cream can prevent the growth of new skin cancers on the face and ears. The cost of trying to prevent skin cancer will be compared to the usual cost of treating skin cancer. Participants are being asked to be a part of this study because the participants have been treated for two or more skin cancers within the past five (5) years. At least one of these cancers occurred on the face or ears. Having had two or more skins cancers in the past 5 years makes it likely that participants will develop additional skin cancers in the future. Exposure to ultraviolet radiation from the sun or artificial sources such as tanning beds is a major cause of basal cell and squamous cell carcinoma of the skin. Using lotions, creams, or gels that contain sunscreens can help protect the skin from premature aging and damage that may lead to skin cancer. The 5-FU skin cream used in this study is FDA-approved to treat some types of skin cancers and spots that might become skin cancer. However, 5-FU skin cream has never been studied to see if it can prevent skin cancer. This drug is not approved by the FDA for how it will be used in this study. In this study, one half of the patients will use the 5-FU cream and the other half will use a skin cream that looks identical to the 5-FU cream but does not have 5-FU or any other active drug in it. Approximately twelve VA medical centers will work together in this study. About one thousand (1000) patients will be in this study. The study is sponsored by the U.S. Department of Veterans Affairs Cooperative Studies Program.